Literature DB >> 2660037

Ovarian hyperstimulation syndrome: an update review.

A Golan1, R Ron-el, A Herman, Y Soffer, Z Weinraub, E Caspi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2660037     DOI： 10.1097/00006254-198906000-00004

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN： 0029-7828            Impact factor:   2.347


× No keyword cloud information.
  119 in total

1.  GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial.

Authors:  Yannis Prapas; Konstantinos Ravanos; Stamatios Petousis; Yannis Panagiotidis; Achilleas Papatheodorou; Chrysoula Margioula-Siarkou; Assunta Iuliano; Giuseppe Gullo; Nikos Prapas
Journal:  J Assist Reprod Genet       Date:  2017-08-03       Impact factor: 3.412

Review 2.  Ovarian hyperstimulation syndrome: a review of pathophysiology.

Authors:  P A Bergh; D Navot
Journal:  J Assist Reprod Genet       Date:  1992-10       Impact factor: 3.412

Review 3.  Understanding ovarian hyperstimulation syndrome.

Authors:  Anne Delbaere; Guillaume Smits; Anne De Leener; Sabine Costagliola; Gilbert Vassart
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

4.  What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study.

Authors:  Theoni B Tarlatzi; Christos A Venetis; Fabienne Devreker; Yvon Englert; Anne Delbaere
Journal:  J Assist Reprod Genet       Date:  2017-07-14       Impact factor: 3.412

Review 5.  [Jugular vein thrombosis caused by hypercoagulability following in-vitro fertilization-activated protein C resistance and immobilization].

Authors:  K Stölzel; S Jovanovic; A E Albers
Journal:  HNO       Date:  2013-03       Impact factor: 1.284

6.  Application of GnRH antagonist in combination with clomiphene citrate and hMG for patients with exaggerated ovarian response in previous IVF/ICSI cycles.

Authors:  Yu-Hung Lin; Kok-Min Seow; Bih-Chwen Hsieh; Lee-Wen Huang; Heng-Ju Chen; Shih-Chia Huang; Chih-Yu Chen; Pei-Hsin Chen; Jiann-Loung Hwang; Chi-Ruey Tzeng
Journal:  J Assist Reprod Genet       Date:  2007-07-17       Impact factor: 3.412

7.  Optimum oocyte retrieved and transfer strategy in young women with normal ovarian reserve undergoing a long treatment protocol: a retrospective cohort study.

Authors:  Yuan-hui Chen; Xiao-hang Xu; Qian Wang; Shao-di Zhang; Li-le Jiang; Cui-lian Zhang; Zhao-jia Ge
Journal:  J Assist Reprod Genet       Date:  2015-09-17       Impact factor: 3.412

8.  Efficacy of different gonadotropin combinations to support ovulation induction in WHO type I anovulation infertility: clinical evidences of human recombinant FSH/human recombinant LH in a 2:1 ratio and highly purified human menopausal gonadotropin stimulation protocols.

Authors:  D Carone; C Caropreso; A Vitti; R Chiappetta
Journal:  J Endocrinol Invest       Date:  2012-10-22       Impact factor: 4.256

9.  Cost analysis model of outpatient management of ovarian hyperstimulation syndrome with paracentesis: "tap early and often" versus hospitalization.

Authors:  John M Csokmay; Belinda J Yauger; Melinda B Henne; Alicia Y Armstrong; John T Queenan; James H Segars
Journal:  Fertil Steril       Date:  2008-11-05       Impact factor: 7.329

10.  Mild/minimal stimulation protocol for ovarian stimulation of patients at high risk of developing ovarian hyperstimulation syndrome.

Authors:  L Rinaldi; F Lisi; H Selman
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.